Genomic rearrangements and sporadic disease

Nature Genetics

Volumn 39, Issue 7S, 2007, Pages S43-S46

  Lupski, James R ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE;

CHROMOSOME ABERRATION; DISEASE ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC TRAIT; GENETIC VARIABILITY; GENOME; GENOME ANALYSIS; HUMAN; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME BREAKAGE; GENE DOSAGE; GENE REARRANGEMENT; GENETIC DISEASES, INBORN; GENOMICS; HUMANS; MUTATION; PHENOTYPE; VARIATION (GENETICS);

EID: 34347349069     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng2084     Document Type: Article

References (69)

1. Kalter, H. & Warkany, J. Medical progress. Congenital malformations: Etiologic factors and their role in prevention (first of two parts). N. Engl. J. Med. 308, 424-431 (1983).
2. Kalter, H. & Warkany, J. Congenital malformations (second of two parts). N. Engl. J. Med. 308, 491-497 (1983).
3. Lee, J.A. & Lupski, J.R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52, 103-121 (2006).
4. Baird, P.A., Anderson, T.W., Newcombe, H.B. & Lowry, R.B. Genetic disorders in children and young adults: A population study. Am. J. Hum. Genet. 42, 677-693 (1988).
5. Kondrashov, A.S. Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases. Hum. Mutat. 21, 12-27 (2003).
6. Nachman, M.W. & Crowell, S.L. Estimate of the mutation rate per nucleotide in humans. Genetics 156, 297-304 (2000).
7. Crow, J.F. The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 1, 40-47 (2000).
8. Crow, J.F. Age and sex effects on human mutation rates: An old problem with new complexities. J. Radial Res. 47 (suppl. B), B75-B82 (2006).
9. Goriely, A., McVean, G.A., Rojmyr, M., Ingemarsson, B. & Wilkie, A.O. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301, 643-646 (2003).
10. Szigeti, K., Garcia, C.A. & Lupski, J.R. Charcot-Marie-Tooth disease and related hereditary polyneuropathies: Molecular diagnostics determine aspects of medical management. Genet. Med. 8, 86-92 (2006).
11. Wise, C.A. et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum. Genet. 53, 853-863 (1993).
12. Nelis, E. et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur. J. Hum. Genet. 4, 25-33 (1996).
13. Hoogendijk, J.E. et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 339, 1081-1082 (1992).
14. Potocki, L. et al. DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. Am. J. Hum. Genet. 64, 471-478 (1999).
15. Lupski, J.R. 2002 Curt Stern Award address. Genomic disorders recombination-based disease resulting from genomic architecture. Am. J. Hum. Genet. 72, 246-252 (2003).
16. Shaw-Smith, C. et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J. Med. Genet.41, 241-248 (2004).
17. Iafrate, A.J. et al. Detection of large-scale variation in the human genome. Nat. Genet. 36, 949-951 (2004).
18. Sebat, J. et al. Large-scale copy number polymorphism in the human genome. Science 305, 525-528 (2004).
19. Newman, T.L. et al. A genome-wide survey of structural variation between human and chimpanzee. Genome Res. 15, 1344-1356 (2005).
20. Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444-454 (2006).
21. Khaja, R. et al. Genome assembly comparison identifies structural variants in the human genome. Nat. Genet. 38, 1413-1418 (2006).
22. Wong, K.K. et al. A comprehensive analysis of common copy-number variations in the human genome. Am. J. Hum. Genet. 80, 91-104 (2007).
23. Fiegler, H. et al. Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res. 16, 1566-1574 (2006).
24. Komura, D. et al. Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res. 16, 1575-1584 (2006).
25. Lupski, J.R. Structural variation in the human genome. N. Engl. J. Med. 356, 1169-1171 (2007).
26. Lupski, J.R. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14, 417-422 (1998).
27. Stankiewicz, P. & Lupski, J.R. Genome architecture, rearrangements and genomic disorders. Trends Genet. 18, 74-82 (2002).
28. Shaffer, L.G. & Lupski, J.R. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu. Rev. Genet. 34, 297-329 (2000).
29. Coulondre, C., Miller, J.H., Farabaugh, P.J. & Gilbert, W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274, 775-780 (1978).
30. Cooper, D.N. & Youssoufian, H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78, 151-155 (1988).
31. Lupski, J.R. & Chance, P.F. Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: The CMT1A duplication and HNPP deletion. In Peripheral Neuropathy(eds. Dyck, P.J. & Thomas, P.K.) Ch. 70, 1659-1680 (Elsevier, Philadelphia, 2005).
32. Lupski, J.R. & Garcia, A. Charcot-Marie-Tooth peripheral neuropathies and related disorders. in The Metabolic and Molecular Bases of Inherited Diseases (eds. Scriver, C.R. et al.) Ch. 227, 5759-5788 (McGraw-Hill, New York, 2001).
33. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin. Genet. 6, 98-118 (1974).
34. Shy, M.E., Lupski, J.R., Chance, P.F., Klein, C.J. & Dyck, P.J. Hereditary motor and sensory neuropathies. in Peripheral Neuropathy Vol. I (eds. Dyck, P.J. & Thomas, P.K.) Ch. 69, 1623-1658 (Elsevier, Philadelphia, 2005).
35. Bort, S., Martinez, F. & Palau, F. Prevalence and parental origin of de novo 1.5-Mb duplication in Charcot-Marie-Tooth disease type 1A. Am. J. Hum. Genet. 60, 230-233 (1997).
36. Marques, W., Jr. et al. 17p duplicated Charcot-Marie-Tooth 1A: Characteristics of a new population. J. Neurol. 252, 972-979 (2005).
37. van Ommen, G.J. Frequency of new copy number variation in humans. Nat. Genet. 37, 333-334 (2005).
38. Haldane, J.B.S. The rate of spontaneous mutation of a human gene. J. Genet. 31, 317-326 (1935).
39. Den Dunnen, J.T. et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am. J. Hum. Genet. 45, 835-847 (1989).
40. White, S. et al. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am. J. Hum. Genet. 71, 365-374 (2002).
41. Sharp, A.J. et al. Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet. 77, 78-88 (2005).
42. Sharp, A.J. et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 38, 1038-1042 (2006).
43. Sharp, A.J. et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum. Mol. Genet. 16, 567-572 (2007).
44. Lupski, J.R. & Stankiewicz, P. Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet. 1, E49 (2005).
45. Shaw, C.J. & Lupski, J.R. Implications of human genome architecture for rearrangement-based disorders: The genomic basis of disease. Hum. Mol. Genet. 13 (review issue 1), R57-R64 (2004).
46. Potocki, L. et al. Characterization of the Potocki-Lupski syndrome [dup(17)(p11.2p11.2)] and delineation of a dosage-sensitive critical interval that can convey an autism phe-notype. Am. J. Hum. Genet. 80, 633-649 (2007).
47. Lam, K.-W. & Jeffreys, A.J. Processes of copy-number change in human DNA: The dynamics of a-globin gene deletion. Proc. Natl. Acad. Sci. USA 103, 8921-8927 (2006).
48. Brewer, C., Holloway, S., Zawalnyski, P., Schinzel, A. & FitzPatrick, D. A chromosomal deletion map of human malformations. Am. J. Hum. Genet. 63, 1153-1159 (1998).
49. Brewer, C., Holloway, S., Zawalnyski, P., Schinzel, A. & FitzPatrick, D. A chromosomal duplication map of malformations: Regions of suspected haplo- and triplolethality-and tolerance of segmental aneuploidy-in humans. Am. J. Hum. Genet. 64, 1702-1708 (1999).
50. Kurahashi, H. et al. Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22). Hum. Mol. Genet. 9, 1665-1670 (2000).
51. Edelmann, L. et al. AT-rich palindromes mediate the constitutional t(11;22) translocation. Am. J. Hum. Genet. 68, 1-13 (2001).
52. Kurahashi, H. & Emanuel, B.S. Unexpectedly high rate of de novo constitutional t(11;22) translocations in sperm from normal males. Nat. Genet. 29, 139-140 (2001).
53. Lupski, J.R. Genome structural variation and sporadic disease traits. Nat. Genet. 38, 974-976 (2006).
54. Kato, T. et al. Genetic variation affects de novo translocation frequency. Science 311, 971 (2006).
55. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007).
56. Eichler, E.E. Segmental duplications: What’s missing, misassigned, and misassem-bled-and should we care? Genome Res. 11, 653-656 (2001).
57. Vorstman, J.A. et al. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psychiatry 11, 18-28 (2006).
58. Jacquemont, M.L. et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J. Med. Genet. 43, 843-849 (2006).
59. Cheung, S.W. et al. Development and validation of a CGH microarray for clinical cyto- genetic diagnosis. Genet. Med. 7, 422-432 (2005).
60. Bejjani, B.A. et al. Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: Is less more? Am. J. Med. Genet. A. 134, 259-267 (2005).
61. Shaffer, L.G. et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J. Pediatr. 149, 98-102 (2006).
62. Lu, X. et al. Clinical implementation of chromosomal microarray analysis: Summary of 2513 consecutive postnatal cases. PLoS ONE3, E327 (2007).
63. Chen, K.-S. et al. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nat. Genet. 17, 154-163 (1997).
64. Potocki, L. et al. Molecular mechanism for duplication 17p11.2-the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat. Genet. 24, 84-87 (2000).
65. Stankiewicz, P. et al. Genome architecture catalyzes nonrecurrent chromosomal rearrangements. Am. J. Hum. Genet. 72, 1101-1116 (2003).
66. Bi, W. et al. Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2. Am. J. Hum. Genet. 73, 1302-1315 (2003).
67. Shaw, C.J., Withers, M.A. & Lupski, J.R. Uncommon deletion of the Smith-Magenis syndrome region can be recurrent when alternate low-copy repeats act as homologous recombination substrates. Am. J. Hum. Genet. 75, 75-81 (2004).
68. Stankiewicz, P., Bi, W. & Lupski, J.R. Smith-Magenis syndrome deletion, reciprocal duplication dup(17)(p11.2p11.2), and other proximal 17p rearrangements. in Genomic Disorders (eds. Lupski, J.R. & Stankiewicz, P.) 179-191 (Humana, Totowa, New Jersey, USA, 2006).
69. Lee, J.A. et al. Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum. Mol. Genet. 15, 2250-2265 (2006).